Lipids & metabolic liver disease

Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults

J Clin Endocrinol MetabPublished Cross-sectional study

Authors' conclusion

Impaired central sensitivity to FT3 was associated with MAFLD and its progression to liver fibrosis. More prospective and mechanism studies are warranted to confirm these conclusions.

Study context

Population
Chinese euthyroid adults; liver steatosis and fibrosis diagnosed by vibration-controlled transient elastography
Participants
7,906 euthyroid adults
Exposure
Q4 vs Q1 of thyroid hormone sensitivity indices
Outcome
Prevalence of MAFLD and of liver fibrosis
Methodological detailscommunity-based
  • Community-based

Main finding

As reported in the abstract

Prevalence of MAFLD
Q4 vs Q1Odds ratio (95% CI)P value
FT3/FT4 ratio
1.62(1.38–1.91)
P < 0.05
TFQIFT3
1.40(1.18–1.65)
P < 0.05

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Prevalence of liver fibrosis in participants with MAFLD, TFQIFT3TFQIFT31.45 (1.03–2.06)P < 0.05

Original publication

Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults. J Clin Endocrinol Metab. Published 31 March 2023. doi:10.1210/clinem/dgad186

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.